OM Pharma Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

We use our expertise in bacterial lysates to address the world’s most significant health challenges from the rise in infectious disease outbreaks to antimicrobial resistance. Currently active in the prevention of respiratory and urinary tract infections, our constantly evolving understanding of how bacterial lysates interact with the immune system motivates us to invest in new indications and new formulations for our lysates. Headquartered in Geneva with affiliates in Peru and Switzerland, our pView more